SNY:NASDAQ
Sanofi SA
$39.56
arrow_upward
+0.13%(+0.050) 1D
$39.75
arrow_upward
+0.48% (+0.19)bedtimeAfter hours
Closed: Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNY...
Open
$40.05
High
$40.05
Low
$39.24
Mkt. cap
96.26B
Avg. vol.
2.65M
Volume
3.05M
Dividend
6.11%
Quarterly dividend
$0.60
Ex-dividend date
May 5, 2026
P/E ratio
21.63
52-wk high
$52.68
52-wk low
$39.18
EPS
$1.83
Beta
0.37
Shares outstanding
2.42B
No. of employees
75K
Open
$40.05
High
$40.05
Low
$39.24
Mkt. cap
96.26B
Avg. vol.
2.65M
Volume
3.05M
Dividend
6.11%
Quarterly dividend
$0.60
Ex-dividend date
May 5, 2026
P/E ratio
21.63
52-wk high
$52.68
52-wk low
$39.18
EPS
$1.83
Beta
0.37
Shares outstanding
2.42B
No. of employees
75K
News stories
From web sources and news partners
AD HOC NEWS
·
12 hours ago
Sanofi stock after-hours at EUR 70.68: plus 0.21 percent
AD HOC NEWS
·
17 hours ago
Argus upgrades Regeneron stock to Buy with USD 850.00 target
AD HOC NEWS
·
18 hours ago
Sanofi expands antibody alliance. Sanofi stock gains 1.39 percent
Ideal Investisseur
·
19 hours ago
After a 17.5% decline over one year, Sanofi shares gain 2% during the session
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is one of the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson | Belén Garijo
Employees74.8K
Founded1973
HeadquartersParis, Île-de-France, France
SectorPharmaceutical industry
Websitesanofi.com